Trends in Prevalence and Control of Hypertension According to the 2017 American College of Cardiology/American Heart Association (ACC/AHA) Guideline

被引:1
|
作者
Dorans, Kirsten S. [1 ,2 ]
Mills, Katherine T. [1 ,2 ]
Liu, Yang [1 ,3 ]
He, Jiang [1 ,2 ,4 ]
机构
[1] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, 1440 Canal St, New Orleans, LA 70112 USA
[2] Tulane Univ, Translat Sci Inst, New Orleans, LA 70118 USA
[3] Soochow Univ, Affiliated Hosp 1, Dept Cardiol, Suzhou, Peoples R China
[4] Tulane Univ, Sch Med, Dept Med, New Orleans, LA 70112 USA
来源
关键词
epidemiology; high blood pressure; hypertension; risk factor; NUTRITION EXAMINATION SURVEY; HIGH BLOOD-PRESSURE; NATIONAL-HEALTH; UNITED-STATES; ADULTS; OLDER;
D O I
10.1161/JAHA.118.008888
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundHypertension is a major risk factor for cardiovascular disease and all-cause mortality. Compared with prior guidelines, the 2017 American College of Cardiology/American Heart Association (ACC/AHA) hypertension guideline recommends lower blood pressure thresholds for defining hypertension, for initiating antihypertensive medication, and for antihypertensive medication treatment goals. Methods and ResultsTo better understand potential impacts of the 2017 guideline, we studied trends in mean systolic blood pressure and diastolic blood pressure, prevalence and burden of hypertension, and proportion of controlled hypertension in the US adult population aged 20 from 1999 through 2016. We used data from 38276 adults from the National Health and Nutrition Examination Survey. Age-standardized prevalence of hypertension decreased from 48.4% in 1999-2000 to 45.4% in 2015-2016. However, absolute burden of hypertension consistently increased, from 87.0million in 1999-2000 to 108.2million in 2015-2016. The age-standardized proportion of controlled hypertension among adults receiving antihypertensive pharmacologic treatment increased from 1999-2000 (25.6%) to 2015-2016 (43.5%). There was not consistent improvement in control throughout the full period among non-Hispanic blacks, individuals aged 60, or those with diabetes mellitus, chronic kidney disease, or high cardiovascular disease risk. ConclusionsBased on the 2017 guideline, from 1999 to 2016, the age-standardized prevalence of hypertension decreased and the proportion of control among those treated for hypertension improved. However, the absolute hypertension burden increased. Among those treated, the control rate did not consistently improve in all subgroups. These data emphasize the need for continuous efforts in the prevention and control of hypertension in the US general population.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Cost Effectiveness of Treating Hypertension According to 2017 American College of Cardiology / American Heart Association Hypertension (2017 ACC / AHA) Guidelines
    Penko, Joanne M.
    Bellows, Brandon K.
    Tajeu, Gabriel S.
    Guzman, David
    Coxson, Pamela G.
    Bibbins-Domingo, Kirsten
    Moran, Andrew E.
    CIRCULATION, 2019, 140
  • [2] Adoption of the 2017 American College of Cardiology/American Heart Association (ACC/AHA) Hypertension Guideline in Hong Kong and implications for local practice
    Wong, C. H.
    Man, M. S.
    Lau, Thomas K. W.
    Wong, C. Y.
    Fong, L. K.
    Luo, Valeria Deng
    HONG KONG MEDICAL JOURNAL, 2022, 28 (01) : 88 - 90
  • [3] Impact of the 2017 American College of Cardiology/American Heart Association Hypertension Guideline on the prevalence of hypertension in young Saudi women
    Al-Mohaissen, Maha
    Al-Obaid, Qumasha
    AlGhamdi, Wafa
    Al-Alyani, Haneen
    Dahman, Sheima
    Al-Wahhabi, Nora
    Al-Awaji, Noura
    Lee, Terry
    EASTERN MEDITERRANEAN HEALTH JOURNAL, 2020, 26 (04) : 426 - 434
  • [4] Perspective to 2020 American College of Cardiology/American Heart Association (ACC/AHA) Guideline for the Management of Patients With Valvular Heart Disease
    Bavry, Anthony A.
    Arnaoutakis, George J.
    CIRCULATION, 2021, 143 (05) : 407 - 409
  • [5] The 2017 American College of Cardiology/American Heart Association Hypertension Guideline: A Resource for Practicing Clinicians
    Carey, Robert M.
    Whelton, Paul K.
    ANNALS OF INTERNAL MEDICINE, 2018, 168 (05) : 359 - +
  • [6] Impact of the 2017 American Heart Association and American College of Cardiology hypertension guideline in aged individuals
    Chowdhury, Enayet Karim
    Ernst, Michael E.
    Nelson, Mark
    Margolis, Karen
    Beilin, Lawrie J.
    Johnston, Collin
    Woods, Robyn
    Murray, Anne
    Wolfe, Rory
    Storey, Elsdon
    Shah, Raj C.
    Lockery, Jessica
    Tonkin, Andrew
    Newman, Anne
    Abhayaratna, Walter
    Stocks, Nigel
    Fitzgerald, Sharyn
    Orchard, Suzanne
    Trevaks, Ruth
    Donnan, Geoffrey
    Grimm, R.
    McNeil, John
    Reid, Christopher M.
    JOURNAL OF HYPERTENSION, 2020, 38 (12) : 2527 - 2536
  • [7] The 2017 American College of Cardiology/American Heart Association hypertension guideline and opportunities for community pharmacists
    Dixon, Dave L.
    Salgado, Teresa M.
    Caldas, Lauren M.
    Van Tassell, Benjamin W.
    Sisson, Evan M.
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2018, 58 (04) : 382 - 386
  • [8] 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
    Nishimura, Rick A.
    Otto, Catherine M.
    Bonow, Robert O.
    Carabello, Blase A.
    Erwin, John P., III
    Fleisher, Lee A.
    Jneid, Hani
    Mack, Michael J.
    Gara, Patrick T. O.
    Rigolin, Vera H.
    Sundt, Thoralf M., III
    CIRCULATION, 2017, 135 (25) : E1159 - U119
  • [9] The 2017 American College of Cardiology/American Heart Association Hypertension Guideline and Blood Pressure in Older Adults
    Wang, Michael C.
    Petito, Lucia C.
    Pool, Lindsay R.
    Foti, Kathryn
    Juraschek, Stephen P.
    Mcevoy, John W.
    Nambi, Vijay
    Carnethon, Mercedes R.
    Michos, Erin D.
    Khan, Sadiya S.
    AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2023, 65 (04) : 640 - 648
  • [10] Prevalence and treatment of hypertension in China: impacts of 2017 American College of Cardiology/American Heart Association High Blood Pressure Guideline
    Chao Yang
    Jinwei Wang
    Bixia Gao
    Yan Zhang
    Fang Wang
    Luxia Zhang
    Minghui Zhao
    Yong Huo
    Science Bulletin, 2018, 63 (08) : 488 - 493